The role of neuropeptides such as nerve growth factor (NGF) in controlling this nerve overgrowth was described in experimental skin injury [47] and is supported by the clinical evidence of keratoconus progression after injury-induced fifth nerve palsy [48]. This evidence concerns the gene NGF and injury.